When and how to analyse TP53 status (both mutations and 17p deletions) in CLL patients: the ERIC experience.
Authors | |
---|---|
Year of publication | 2016 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
Authors | |
---|---|
Year of publication | 2016 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |